| Financial Year |
March 31 2023 |
| Monetary Funds |
1,833,911,588.22 |
| Held-for-trading Financial Assets |
1,057,259,848.46 |
| Notes Receivable |
187,204,042.88 |
| Accounts Receivable |
89,522,891.70 |
| Advances to Suppliers |
32,834,352.72 |
| Other Receivables |
19,037,343.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
89,818,180.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,824,775.47 |
| Total Current Assets |
3,311,413,022.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
87,720,903.30 |
| Investment Properties |
161,256,562.82 |
| Fixed Assetes |
865,975,619.53 |
| Under-construction Projects |
41,526,836.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
172,881,784.39 |
| R&D expenses |
6,452,830.02 |
| Goodwill |
26,133,365.56 |
| Long-Term Deferred and Prepaid Expenses |
19,966,467.01 |
| Deferred Income Tax Assets |
4,736,109.16 |
| Other Non-Current Assets |
20,032,288.46 |
| Sub-Total of Non-Current Assets |
1,507,248,129.11 |
| Total Assets |
4,818,661,151.84 |
| Short-Term Loans |
6,145,670.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
38,551,888.96 |
| Accounts Received In Advance |
4,383,501.94 |
| Employee Compensation Payable |
147,139,597.77 |
| Taxes Payable |
123,588,499.35 |
| Interest Payable |
2,041,425.00 |
| Dividend Payable |
241,546,719.86 |
| Other payables |
335,846,937.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,209,357.58 |
| Sub-Total of Current Liabilities |
861,598,965.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,500,417.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
85,610,102.80 |
| Total Liabilities |
947,209,068.42 |
| Paid-In Capital(Or Share Stock) |
234,331,485.00 |
| Capital Surplus |
63,244,992.58 |
| Surplus Reserve |
127,957,246.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,322,280,098.57 |
| Minority Stockholder's Interest |
1,123,638,260.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,747,813,822.68 |
| Owner's Equity（Stockholder's Equity） |
3,871,452,083.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,818,661,151.84 |
